These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 29635629

  • 1. Temocillin against Enterobacteriaceae isolates from community-acquired urinary tract infections: low rate of resistance and good accuracy of routine susceptibility testing methods.
    Alexandre K, Réveillon-Istin M, Fabre R, Delbos V, Etienne M, Pestel-Caron M, Dahyot S, Caron F.
    J Antimicrob Chemother; 2018 Jul 01; 73(7):1848-1853. PubMed ID: 29635629
    [Abstract] [Full Text] [Related]

  • 2. Activity of temocillin and 15 other agents, including fosfomycin and colistin, against Enterobacteriaceae in Hong Kong.
    Ip M, Lai CK, Fung KSC, Wong KT, Zhu C, Van de Velde S, Tsang DN, Hawkey P.
    Eur J Clin Microbiol Infect Dis; 2017 Dec 01; 36(12):2491-2494. PubMed ID: 28840351
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study.
    Cuevas O, Cercenado E, Gimeno M, Marín M, Coronel P, Bouza E, Spanish Urinary Tract Infection Study Group (SUTIS).
    Diagn Microbiol Infect Dis; 2010 Jul 01; 67(3):251-60. PubMed ID: 20542206
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
    Rodriguez-Villalobos H, Malaviolle V, Frankard J, de Mendonça R, Nonhoff C, Struelens MJ.
    J Antimicrob Chemother; 2006 Apr 01; 57(4):771-4. PubMed ID: 16501056
    [Abstract] [Full Text] [Related]

  • 7. Comparison of disc diffusion, Etest and agar dilution for susceptibility testing of colistin against Enterobacteriaceae.
    Maalej SM, Meziou MR, Rhimi FM, Hammami A.
    Lett Appl Microbiol; 2011 Nov 01; 53(5):546-51. PubMed ID: 21895730
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa and Enterobacteriaceae recovered in Spanish medical centres: Results of the CENIT study.
    Tato M, García-Castillo M, Bofarull AM, Cantón R, CENIT Study Group.
    Int J Antimicrob Agents; 2015 Nov 01; 46(5):502-10. PubMed ID: 26315199
    [Abstract] [Full Text] [Related]

  • 9. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P, Boroumand MA, Rahbar M, Douraghi M.
    Microb Drug Resist; 2018 Jun 01; 24(5):607-612. PubMed ID: 29064348
    [Abstract] [Full Text] [Related]

  • 10. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
    Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, Woodford N.
    Int J Antimicrob Agents; 2011 May 01; 37(5):415-9. PubMed ID: 21429716
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Detection of CTX-M-15 beta-lactamases in Enterobacteriaceae causing hospital- and community-acquired urinary tract infections as early as 2004, in Dar es Salaam, Tanzania.
    Manyahi J, Moyo SJ, Tellevik MG, Ndugulile F, Urassa W, Blomberg B, Langeland N.
    BMC Infect Dis; 2017 Apr 17; 17(1):282. PubMed ID: 28415986
    [Abstract] [Full Text] [Related]

  • 16. Temocillin versus carbapenems for urinary tract infection due to ESBL-producing Enterobacteriaceae: a multicenter matched case-control study.
    Delory T, Gravier S, Le Pluart D, Gaube G, Simeon S, Davido B, Piet E, Lepeule R, Lesprit P, Lafaurie M.
    Int J Antimicrob Agents; 2021 Jul 17; 58(1):106361. PubMed ID: 34000372
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
    Lee YL, Chen YS, Toh HS, Huang CC, Liu YM, Ho CM, Lu PL, Ko WC, Chen YH, Wang JH, Tang HJ, Yu KW, Liu YC, Chuang YC, Liu CE, Hsueh PR.
    Int J Antimicrob Agents; 2012 Jun 17; 40 Suppl():S29-36. PubMed ID: 22749056
    [Abstract] [Full Text] [Related]

  • 20. Polymyxin B Etest® compared with gold-standard broth microdilution in carbapenem-resistant Enterobacteriaceae exhibiting a wide range of polymyxin B MICs.
    Kulengowski B, Ribes JA, Burgess DS.
    Clin Microbiol Infect; 2019 Jan 17; 25(1):92-95. PubMed ID: 29674129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.